Background: Pertussis remains an important respiratory infection in children, but clinical diagnosis can be difficult because classic manifestations may be absent or nonspecific. IS481-targeted molecular detection provides high sensitivity but is not completely specific for Bordetella pertussis . This study assessed IS481-positive Bordetella DNA among children with clinically suspected pertussis and compared conventional culture with real-time PCR. Methods: This prospective observational study included 95 children aged 3 months to 12 years with clinically suspected pertussis, enrolled between May 2021 and May 2022. Nasopharyngeal specimens were tested by conventional culture and IS481-targeted real-time PCR. Associations between IS481 positivity and demographic, clinical, and vaccination characteristics were assessed using Fisher exact test. Results: IS481-positive Bordetella DNA was detected in 7/95 children (7.4%), whereas culture identified 1 Bordetella pertussis isolate (1.1%). The culture-positive specimen was also PCR-positive, while 6 additional specimens were PCR-positive but culture-negative. Younger age ( P =0.004) and incomplete primary vaccination ( P =0.001) were significantly associated with IS481 positivity. No significant associations were observed with the clinical characteristics evaluated. Conclusions: IS481-positive specimens could not be definitively attributed to B. pertussis without additional species-specific targets. Nevertheless, IS481-targeted real-time PCR detected more Bordetella -positive specimens than culture and may improve laboratory detection among children with suspected pertussis.
No takes yet. Share an insight, caveat, or question.
Shanmugam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: